| during active phases of the disease | 5 | temporal |
| clearly | 4 | manner |
| in altering chromatin | 4 | other |
| effect → be → observed | 104 |
| effect → be → demonstrated | 8 |
| negative | neutral | positive |
| 0.179 | 0.707 | 0.114 |
| Raw frequency | 112 |
| Normalized frequency | 0.827 |
| Modifier score | 0.057 |
| Perplexity | 52.121 |